Table 2 Information available at the start of LED phototherapy
Hospital A | Hospital B | |
|---|---|---|
n = 251 | n = 339 | |
At start of phototherapy | ||
Age (days): Median (IQR) | 3.0 (2.0-5.0) | 3.0 (2.0-5.0) |
TSB (μmol/L)a: Median (IQR) | 311 (224–445) | 325 (234–473) |
Risk factors for hyperbilirubinaemia | ||
Preterm (<37 weeks’)c: n (%) | 38 (15.3 %) | 85 (25.5 %) |
Previous sibling treated: n (%) | 1 (0.4 %) | 66 (19.5 %) |
Significant bruising: n (%) | 2 (0.8 %) | 9 (2.7 %) |
Breastfeeding and feeding poorly: n (%) | 25 (10.0 %) | Unclear |
Suspected cause (multiple selections permitted) | ||
Suspected infection: n (%) | 158 (63.0 %) | 183 (54.0 %) |
G6PD deficiencyd: n (%) | 91 (36.3 %) | 58 (17.1 %) |
ABO incompatibility: n (%) | 43 (17.1 %) | 52 (15.3 %) |
Rhesus incompatibility: n (%) | 4 (1.6 %) | 2 (0.6 %) |
Not specified: n (%) | 14 (5.6 %) | 32 (9.4 %) |